by The global automated microbiology market size was valued at USD 7.95 billion in 2024 and is expected to attain around USD 22.03 billion by 2034, a CAGR of 10.73%.
Key Points
-
North America emerged as the top market contributor, holding more than 41% of the market share in 2024.
-
Asia Pacific is forecasted to grow at the most accelerated pace during the studied timeframe.
-
The reagents and kits category dominated the product segment with a 49% share in 2024.
-
Instruments are set to witness the fastest growth within the product category.
-
The fully automated segment led in 2024, surpassing other automation types.
-
Clinical diagnostics remained the largest application segment in terms of market share.
-
The biopharmaceutical production segment is poised to grow at the highest CAGR over the forecast period.
-
With a 45% share, hospitals and diagnostic laboratories emerged as the top end-use category in 2024.
-
Pharmaceutical and biotechnology firms are expected to expand at the highest rate during the forecast period.
AI Impact on the Automated Microbiology Market
-
Enhanced Diagnostic Accuracy: AI algorithms improve the precision of microbial identification and susceptibility testing by analyzing complex data sets. This leads to faster and more accurate diagnoses of infectious diseases.
-
Automation of Laboratory Processes: AI facilitates the automation of various laboratory workflows, reducing manual intervention and human errors. This increases efficiency and allows for high-throughput testing, essential in clinical settings.
-
Predictive Analytics: AI-driven analytics can forecast antibiotic resistance patterns, enabling healthcare providers to make informed decisions regarding treatment options. This is particularly crucial in managing antimicrobial resistance (AMR).
-
Real-time Data Processing: AI systems enable real-time monitoring and analysis of microbiological data, enhancing laboratory operations and allowing for immediate clinical decision-making.
Growth Factors
The automated microbiology market is experiencing significant growth due to advancements in AI and automation, which enhance diagnostic accuracy, reduce manual errors, and streamline high-throughput testing. The rising prevalence of infectious diseases has increased the demand for faster and more precise diagnostic solutions, enabling early detection and timely treatment. Additionally, growing concerns over antimicrobial resistance (AMR) have emphasized the need for rapid pathogen identification, with automated microbiology providing real-time insights into resistance patterns.
The increased adoption of high-throughput testing in clinical laboratories and research institutions has further driven market expansion by improving workflow efficiency and reducing turnaround times. The rising demand for point-of-care testing (POCT), particularly in remote and resource-limited settings, has also contributed to the market’s growth by improving accessibility to diagnostic services. Government and private sector investments in healthcare infrastructure and research and development have further propelled the market forward.
Stringent regulatory and quality control requirements have led to a greater emphasis on standardized and accurate diagnostic procedures, fostering the adoption of automated microbiology solutions. Additionally, the rapid expansion of pharmaceutical and biotechnology industries has increased the need for advanced microbiology technologies for drug development, quality control, and contamination detection, further boosting market growth.
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview@ https://www.precedenceresearch.com/sample/5722
Market Scope
| Report Coverage | Details |
| Market Size by 2034 | USD 22.03 Billion |
| Market Size in 2025 | USD 8.80 Billion |
| Market Size in 2024 | USD 7.95 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 10.73% |
| Dominated Region | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Product, Automation Type, Application, End use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East |
Automated Microbiology Market Dynamics
Drivers
The rise in hospital-acquired infections and the increasing need for early detection of microbial threats are key drivers of the automated microbiology market. AI-driven innovations in diagnostic tools and laboratory automation have enhanced testing accuracy and efficiency. Government policies promoting digital transformation in healthcare further accelerate market growth.
Opportunities
The expansion of personalized medicine and precision diagnostics creates new growth opportunities for automated microbiology solutions. Advancements in nanotechnology and biosensors are paving the way for next-generation microbial detection systems. The development of fully automated microbiology labs is also an emerging trend shaping the market landscape.
Challenges
Cost constraints associated with installing and maintaining automated microbiology equipment hinder widespread adoption, particularly in small laboratories and developing regions. The need for continuous software and hardware updates to keep up with technological advancements presents an ongoing challenge. Additionally, interoperability issues with existing laboratory information systems can complicate workflow integration.
Regional Insights
North America continues to be the dominant player in the market due to its advanced research facilities and high demand for automated diagnostic solutions. Europe’s strong regulatory standards and funding for infection control measures contribute to its market growth. The Asia-Pacific region, particularly China and India, is witnessing a surge in demand for automated microbiology due to increasing investments in healthcare modernization.
Automated Microbiology Market Companies
- BD
- QIAGEN
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Danaher
- Merck KGaA
- bioMérieux
- Abbott
- DiaSorin S.p.A.
- BioRad Laboratories, Inc.
Latest Announcement by Market Leaders
- In February 2025, QIAGEN announced the official opening of a new data center in Melbourne, Australia, designed to strengthen its global bioinformatics leadership position in this region of the world. This latest addition reflects QIAGEN’s ongoing commitment to enhance its bioinformatics data infrastructure.
- In January 2025, Diatech Pharmacogenetics announced an expansion of its collaboration with Merck Serono Middle East Ltd., affiliates of Merck KGaA (“Merck”). The collaboration aims to improve patient access to RAS biomarker testing in Middle East and Africa. Targeted therapy against cancer may be used in combination with chemotherapy for patients with specific genetic mutations, such as KRAS, BRAF, and NRAS mutations.
Recent Developments
- In January 2024, Rapid Micro Biosystems, Inc. announced that Samsung Biologics has chosen the Growth Direct platform to automate its microbial quality control processes, enhancing efficiency, strengthening data integrity, and enabling scalable quality control operations.
- In November 2023, London Health Sciences Centre (LHSC) and St. Joseph’s Heath Care London (St. Joseph’s) unveiled the installation of a Total Laboratory Automation (TLA) system within the clinical microbiology laboratory. The TLA system is the first of its kind to be installed in the world, making London an international flagship site for innovation in clinical microbiology.
- In January 2023, BD (Becton, Dickinson, and Company) launched a robotic track system for its BD Kiestra microbiology laboratory solution, designed to automate specimen processing, potentially minimizing manual effort and reducing result turnaround time.
Segments Covered in the Report
By Product
- Instruments
- Automated Microbial Identification Systems
- Automated Blood Culture Systems
- Automated Colony Counters
- Automated Sample Preparation Systems
- Automated Antibiotic Susceptibility Testing (AST) Systems
- Other Instruments
- Reagents and Kits
- Culture Media
- Stains and Dyes
- Assay Kits and Panels
- Others
- Software
By Automation Type
- Fully Automated
- Semi-Automated
By Application
- Biopharmaceutical Production
- Clinical Diagnostics
- Environmental and Water Testing
- Food and Beverage Testing
- Other Applications
By End-use
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Other End Use
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Also Read: Canine Atopic Dermatitis Market
Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/
- Automated Microbiology Market Size to Attain USD 22.03 Billion by 2034 - March 24, 2025
- Canine Atopic Dermatitis Market Size to Surpass USD 6.40 Billion by 2034 - March 24, 2025
- PD-1 Inhibitor Drugs Market Size to Attain USD 179.77 Billion by 2034 - March 21, 2025
